Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-07

Clinical Trial Update: Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women [Phase 3]

View source ↗

Summary

Phase 3 trial update for a quadrivalent HPV vaccine aiming to prevent anal HPV infection in HIV-infected individuals; results completed with posted results in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • quadrivalent HPV vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2017-02-07